References
- Boulton AJ. The pathway to foot ulceration in diabetes. Med Clin North Am. 2013;97:775-90. doi: 10.1016/j.mcna.2013.03.007.
- Gregg EW, Sorlie P, Paulose-Ram R, Gu Q, Eberhardt MS, Wolz M, et al. Prevalence of lower-extremity disease in the US adult population ≥40 years of age with and without diabetes: 1999-2000 national health and nutrition examination survey. Diabetes Care. 2004;27:1591-7. doi: 10.2337/diacare.27.7.1591.
- Kram HB, Appel PL, Shoemaker WC. Prediction of below-knee amputation wound healing using noninvasive laser Doppler velocimetry. Am J Surg. 1989;158:29-31. doi: 10.1016/0002-9610(89)90310-3.
- Ratliff DA, Clyne CA, Chant AD, Webster JH. Prediction of amputation wound healing: the role of transcutaneous pO2 assessment. Br J Surg. 1984;71:219-22. doi: 10.1002/bjs.1800710320.
- Reiber GE, Pecoraro RE, Koepsell TD. Risk factors for amputation in patients with diabetes mellitus. A case-control study. Ann Intern Med. 1992;117:97-105. doi: 10.7326/0003-4819-117-2-97.
- Zhou ZY, Liu YK, Chen HL, Yang HL, Liu F. HbA1c and lower extremity amputation risk in patients with diabetes: a metaanalysis. Int J Low Extrem Wounds. 2015;14:168-77. doi: 10.1177/1534734615593190.
- Zhao W, Katzmarzyk PT, Horswell R, Wang Y, Johnson J, Heymsfield SB, et al. HbA1c and lower-extremity amputation risk in low-income patients with diabetes. Diabetes Care. 2013;36:3591-8. doi: 10.2337/dc13-0437.
- Matsushita K, Ballew SH, Coresh J, Arima H, Arnlov J, Cirillo M, et al. Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2017;5:718-28. doi: 10.1016/S2213-8587(17)30183-3.
- Kurniawati A, Ismiarto YD, Hsu IL. Prognostic factors for lower extremity amputation in diabetic foot ulcer patients. J Acute Med. 2019;9:59-63. doi: 10.6705/j.jacme.201906_9(2).0003.
- Shevtsova A, Gordiienko I, Tkachenko V, Ushakova G. Ischemiamodified albumin: origins and clinical implications. Dis Markers. 2021;2021:9945424. doi: 10.1155/2021/9945424.
- Sinha MK, Gaze DC, Tippins JR, Collinson PO, Kaski JC. Ischemia modified albumin is a sensitive marker of myocardial ischemia after percutaneous coronary intervention. Circulation. 2003;107:2403-5. doi: 10.1161/01.CIR.0000072764.18315.6B.
- Calhoun JH, Cantrell J, Cobos J, Lacy J, Valdez RR, Hokanson J, et al. Treatment of diabetic foot infections: Wagner classification, therapy, and outcome. Foot Ankle. 1988;9:101-6. doi: 10.1177/107110078800900301.
- Sbarouni E, Georgiadou P, Kremastinos DT, Voudris V. Ischemia modified albumin: is this marker of ischemia ready for prime time use? Hellenic J Cardiol. 2008;49:260-6.
- Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, Tate J, et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem. 2005;51:810-24. doi: 10.1373/clinchem.2004.046292.
- Bourdon E, Loreau N, Blache D. Glucose and free radicals impair the antioxidant properties of serum albumin. FASEB J. 1999;13:233-44. doi: 10.1096/fasebj.13.2.233.
- Chan B, Dodsworth N, Woodrow J, Tucker A, Harris R. Site-specific Nterminal auto-degradation of human serum albumin. Eur J Biochem. 1995;227:524-8. doi: 10.1111/j.1432-1033.1995.tb20419.x.
- Ma SG, Wei CL, Hong B, Yu WN. Ischemia-modified albumin in type 2 diabetic patients with and without peripheral arterial disease. Clinics (Sao Paulo). 2011 ;66:1677-80. doi: 10.1590/s1807-59322011001000003.
- Wukich DK, Ahn J, Raspovic KM, Gottschalk FA, La Fontaine J, Lavery LA. Comparison of transtibial amputations in diabetic patients with and without end-stage renal disease. Foot Ankle Int. 2017;38:388-96. doi: 10.1177/1071100716688073.
- Pollard J, Hamilton GA, Rush SM, Ford LA. Mortality and morbidity after transmetatarsal amputation: retrospective review of 101 cases. J Foot Ankle Surg. 2006;45:91-7. doi: 10.1053/j.jfas.2005.12.011.
- Chen J, Mohler ER 3rd, Xie D, Shlipak MG, Townsend RR, Appel LJ, et al. Risk factors for peripheral arterial disease among patients with chronic kidney disease. Am J Cardiol. 2012;110:136-41. doi: 10.1016/j.amjcard.2012.02.061.
- Dounousi E, Papavasiliou E, Makedou A, Ioannou K, Katopodis KP, Tselepis A, et al. Oxidative stress is progressively enhanced with advancing stages of CKD. Am J Kidney Dis. 2006;48:752-60. doi: 10.1053/j.ajkd.2006.08.015.
- Ruthenborg RJ, Ban JJ, Wazir A, Takeda N, Kim JW. Regulation of wound healing and fibrosis by hypoxia and hypoxia-inducible factor-1. Mol Cells. 2014;37:637-43. doi: 10.14348/molcells.2014.0150.
- Refaai MA, Wright RW, Parvin CA, Gronowski AM, Scott MG, Eby CS. Ischemia-modified albumin increases after skeletal muscle ischemia during arthroscopic knee surgery. Clin Chim Acta. 2006;366:264-8. doi: 10.1016/j.cca.2005.10.020.
- Zapico-Muniz E, Santalo-Bel M, Merce-Muntanola J, Montiel JA, Martinez-Rubio A, Ordonez-Llanos J. Ischemia-modified albumin during skeletal muscle ischemia. Clin Chem. 2004;50:1063-5. doi: 10.1373/clinchem.2003.027789.
- Lee DH, Jeon HK, Park HJ, Shin WS, Lee SW, Youn HJ, et al. Change in ischemia-modified albumin and its clinical significance during exercise stress testing. Circ J. 2010;74:484-9. doi: 10.1253/circj.cj-09-0581.